News Commentary | June 07, 2019
Based on user‑recorded data, the app is able to provide personalized reproductive health advice. The app is part of a growing trend of investments in women's reproductive health; however, this app is redundant, as the market is saturated with period‑tracking apps of varying quality. While there are ... Not part of subscription
News Commentary | June 03, 2019
Biofourmis has now brought its total investment raised to over $40 million. It also just obtained FDA 510(k) clearance for RhythmAnalytics, a cloud‑based software that uses deep learning to extract and interpret more than 15 types of cardiac arrhythmias. This investment round was led by big‑name VCs... To read more, click here.
News Commentary | September 10, 2019
DiaMonTech (Lux Take: Positive) has just secured €7 million in funding just weeks after we interviewed the company. This is a company with a promising noninvasive glucose monitoring technology. Noninvasive glucose monitoring remains the "holy grail" in blood glucose monitoring, and many companies ... Not part of subscription
by Danielle Bradnan
This research study to identify digital biomarkers comes on the heels of other studies based on smartphones and other wearables for early detection of other medical conditions, such as dementia and depression – as well as, in a notable study with Fitbit, the flu. This research is not only important for developing new tools to get a preliminary diagnosis in advance of testing for COVID-19 but also for advancing research for disease and population health management in the years to come after this crisis has passed. Clients should be looking for research partnerships with wearables startups to identify these biomarkers now as a way to not only mitigate the current crisis but also continue future plays in healthcare.
For the original news article, click here .